Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yasuhiro Maeda

Showing results (191-200 of 206) with videos related to

Pageof 21
Sort By:
European Journal of Neurology|February 7, 2022
Serum asymmetric dimethylarginine level correlates with the progression and prognosis of amyotrophic lateral sclerosisKensuke Ikenaka, Yasuhiro Maeda, Yuji Hotta, et al.
BMC Developmental Biology|August 10, 2010
Involvement of the Reck tumor suppressor protein in maternal and embryonic vascular remodeling in miceEdiriweera P S Chandana, Yasuhiro Maeda, Akihiko Ueda, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 12, 2013
Potential contribution of a novel Tax epitope-specific CD4+ T cells to graft-versus-Tax effect in adult T cell leukemia patients after allogeneic hematopoietic stem cell transplantationYotaro Tamai, Atsuhiko Hasegawa, Ayako Takamori, et al.
International Journal of Hematology|January 8, 2010
Randomized trial of response-oriented individualized versus fixed-schedule induction chemotherapy with idarubicin and cytarabine in adult acute myeloid leukemia: the JALSG AML95 studyShigeki Ohtake, Shuichi Miyawaki, Hitoshi Kiyoi, et al.
International Journal of Hematology|February 24, 2012
Efficacy and safety of nilotinib in Japanese patients with imatinib-resistant or -intolerant Ph+ CML or relapsed/refractory Ph+ ALL: a 36-month analysis of a phase I and II studyKensuke Usuki, Arinobu Tojo, Yasuhiro Maeda, et al.
Cancer Science|November 27, 2021
Decreased expression of T-cell-associated immune markers predicts poor prognosis in patients with follicular lymphomaShinya Rai, Hiroaki Inoue, Kazuko Sakai, et al.
Molecular Cancer Therapeutics|December 6, 2015
Specific Antileukemic Activity of PD0332991, a CDK4/6 Inhibitor, against Philadelphia Chromosome-Positive Lymphoid LeukemiaAtsushi Nemoto, Satoshi Saida, Itaru Kato, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 20, 2015
Prognostic Significance of Tryptophan Catabolism in Adult T-cell Leukemia/LymphomaAyako Masaki, Takashi Ishida, Yasuhiro Maeda, et al.
International Journal of Hematology|September 11, 2010
Intensified consolidation therapy with dose-escalated doxorubicin did not improve the prognosis of adults with acute lymphoblastic leukemia: the JALSG-ALL97 studyItsuro Jinnai, Tohru Sakura, Motohiro Tsuzuki, et al.
Journal of Gastroenterology|May 17, 2018
Anti-ganglionic AChR antibodies in Japanese patients with motility disordersAkihiro Mukaino, Hitomi Minami, Hajime Isomoto, et al.
Pageof 21

Showing results (191-200 of 206) with videos related to

Sort By:
Pageof 21
European Journal of Neurology|February 7, 2022
Serum asymmetric dimethylarginine level correlates with the progression and prognosis of amyotrophic lateral sclerosisKensuke Ikenaka, Yasuhiro Maeda, Yuji Hotta, et al.
BMC Developmental Biology|August 10, 2010
Involvement of the Reck tumor suppressor protein in maternal and embryonic vascular remodeling in miceEdiriweera P S Chandana, Yasuhiro Maeda, Akihiko Ueda, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 12, 2013
Potential contribution of a novel Tax epitope-specific CD4+ T cells to graft-versus-Tax effect in adult T cell leukemia patients after allogeneic hematopoietic stem cell transplantationYotaro Tamai, Atsuhiko Hasegawa, Ayako Takamori, et al.
International Journal of Hematology|January 8, 2010
Randomized trial of response-oriented individualized versus fixed-schedule induction chemotherapy with idarubicin and cytarabine in adult acute myeloid leukemia: the JALSG AML95 studyShigeki Ohtake, Shuichi Miyawaki, Hitoshi Kiyoi, et al.
International Journal of Hematology|February 24, 2012
Efficacy and safety of nilotinib in Japanese patients with imatinib-resistant or -intolerant Ph+ CML or relapsed/refractory Ph+ ALL: a 36-month analysis of a phase I and II studyKensuke Usuki, Arinobu Tojo, Yasuhiro Maeda, et al.
Cancer Science|November 27, 2021
Decreased expression of T-cell-associated immune markers predicts poor prognosis in patients with follicular lymphomaShinya Rai, Hiroaki Inoue, Kazuko Sakai, et al.
Molecular Cancer Therapeutics|December 6, 2015
Specific Antileukemic Activity of PD0332991, a CDK4/6 Inhibitor, against Philadelphia Chromosome-Positive Lymphoid LeukemiaAtsushi Nemoto, Satoshi Saida, Itaru Kato, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 20, 2015
Prognostic Significance of Tryptophan Catabolism in Adult T-cell Leukemia/LymphomaAyako Masaki, Takashi Ishida, Yasuhiro Maeda, et al.
International Journal of Hematology|September 11, 2010
Intensified consolidation therapy with dose-escalated doxorubicin did not improve the prognosis of adults with acute lymphoblastic leukemia: the JALSG-ALL97 studyItsuro Jinnai, Tohru Sakura, Motohiro Tsuzuki, et al.
Journal of Gastroenterology|May 17, 2018
Anti-ganglionic AChR antibodies in Japanese patients with motility disordersAkihiro Mukaino, Hitomi Minami, Hajime Isomoto, et al.
Pageof 21